AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

The FTSE 100 was up 0.2 per cent after the first hour of trading, having finished on a record high of 8,871.31 on Thursday.

This single-arm, multicenter Phase II study assessed the efficacy and safety of olverembatinib in combination with the VP (vindesine+prednisone) regimen (OVP) in the first-line treatment of adult ...

Cinclus Pharma AB (publ), a clinical-stage pharmaceutical company developing next generation treatments for acid-related diseases, today announced that the European Medicines Agency (EMA) and the US F ...

Jeremy Skillington, CEO of LSE-listed Poolbeg Pharma, which has programmes targeting areas of high unmet medical need, ...

The global patented drugs market revenue was around US$ 814.4 billion in 2022 and is estimated to reach US$ 1,456.5 billion by 2032 is growing at a compound annual growth rate (CAGR) of 6.0% during ...